Stock search

Ticker or company name

Compare stocks

Market: US

  • BDXBecton Dickinson
  • HUMHumana
  • IDXXIdexx Laboratories

Add stock

Ticker or company

Summary

BDX
Becton Dickinson
$216,47Down −0,72%
Year: Up +44%
38/100Ratio would not consider buying
Open stock page
HUM
Humana
$461,25Up +2,50%
Year: Up +90%
61/100Ratio would watch
Open stock page
IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Best scoreRatio would consider buying
Open stock page

Verdict

IDXX has the best score (83). HUM grows revenue the fastest. BDX is the cheapest by forward P/E. HUM has the lowest debt load. IDXX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBDX2 ✓ 2 — 4 ✕HUM5 ✓ 1 — 3 ✕IDXX7 ✓ 1 — 1 ✕
P/E vs its history51,844,047,2
P/E vs industry51,844,047,2
Forward P/E14,926,933,5
Revenue growth, YoY−2,6%+22,0%+11,9%
EPS growth, YoY−39,4%−3,6%+17,7%
Net margin4,5%0,8%25,4%
Net debt / EBITDA2,9−4,50,1
Free cash flown/a—$3,14 bn$1,30 bn
Share count over a year−4,2%+0,9%−2,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBDXTTMHUMTTMIDXXTTMIndustry medianTTM
P/E TTM ↓Worst: 51,8Best: 44,047,225,1
Forward P/E ↓Best: 14,926,9Worst: 33,516,2
PEG ↓−27,1Best: 1,9Worst: 2,82,2
P/S TTM ↓2,9Best: 0,4Worst: 12,02,2
EV/EBITDA ↓Best: 16,420,0Worst: 33,917,3
P/FCF ↓21,5Best: 11,0Worst: 42,919,5

Price, %

  • BDXn/a
  • HUMn/a
  • IDXXn/a

Returns

Best WorstNo mark — in between

PeriodBDXHUMIDXX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BDXHUMIDXX
Share of “buy”Worst: 57%59%Best: 67%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”Worst: +2,2%Best: +9,4%+3,7%
Insiders over 12 monthssales $3,38 msales $2,43 msales $58,4 m

Details are on each stock page.